Your browser doesn't support javascript.
loading
Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model.
Sharma, Rupali; Earla, Bhargav; Baidoo, Kwamena E; Zeiger, Martha A; Madigan, James P; Escorcia, Freddy E; Sadowski, Samira M.
Afiliação
  • Sharma R; Endocrine Surgery Section, Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Earla B; Endocrine Surgery Section, Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Baidoo KE; UAB Heersink School of Medicine, Birmingham, Alabama.
  • Zeiger MA; Molecular Imaging Branch, Radiation Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Madigan JP; Office of Surgeon Scientists Programs, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Escorcia FE; Endocrine Surgery Section, Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Sadowski SM; Molecular Imaging Branch, Radiation Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
Mol Cancer Ther ; 22(9): 1052-1062, 2023 09 05.
Article em En | MEDLINE | ID: mdl-37487000
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Tumores Neuroendócrinos / Tumores Neuroectodérmicos Primitivos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Tumores Neuroendócrinos / Tumores Neuroectodérmicos Primitivos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article